HRP20110492T1 - Asimetrična alkilacija karbonila - Google Patents
Asimetrična alkilacija karbonila Download PDFInfo
- Publication number
- HRP20110492T1 HRP20110492T1 HR20110492T HRP20110492T HRP20110492T1 HR P20110492 T1 HRP20110492 T1 HR P20110492T1 HR 20110492 T HR20110492 T HR 20110492T HR P20110492 T HRP20110492 T HR P20110492T HR P20110492 T1 HRP20110492 T1 HR P20110492T1
- Authority
- HR
- Croatia
- Prior art keywords
- group
- compound
- alkyl
- aryl
- chiral
- Prior art date
Links
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 title claims abstract 8
- 238000005804 alkylation reaction Methods 0.000 title claims abstract 5
- 230000029936 alkylation Effects 0.000 title claims abstract 4
- 238000000034 method Methods 0.000 claims abstract 26
- 150000001642 boronic acid derivatives Chemical class 0.000 claims abstract 11
- 150000001875 compounds Chemical class 0.000 claims abstract 11
- PQMFVUNERGGBPG-UHFFFAOYSA-N (6-bromopyridin-2-yl)hydrazine Chemical compound NNC1=CC=CC(Br)=N1 PQMFVUNERGGBPG-UHFFFAOYSA-N 0.000 claims abstract 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract 4
- 150000002902 organometallic compounds Chemical class 0.000 claims abstract 4
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims abstract 2
- 229960004341 escitalopram Drugs 0.000 claims abstract 2
- WSEQXVZVJXJVFP-FQEVSTJZSA-N escitalopram Chemical compound C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-FQEVSTJZSA-N 0.000 claims abstract 2
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 claims 10
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 6
- 150000001721 carbon Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- 229910052796 boron Inorganic materials 0.000 claims 4
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical class C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 claims 3
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical class C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 3
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 150000002916 oxazoles Chemical class 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims 3
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical class C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 claims 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 2
- -1 C2-10-alkynyl Chemical group 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001414 amino alcohols Chemical class 0.000 claims 2
- 239000012752 auxiliary agent Substances 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical compound C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 claims 2
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 150000002009 diols Chemical class 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 150000002901 organomagnesium compounds Chemical class 0.000 claims 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical group OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 claims 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 claims 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- FMCGSUUBYTWNDP-GXSJLCMTSA-N (+)-N-methylpseudoephedrine Chemical compound CN(C)[C@@H](C)[C@@H](O)C1=CC=CC=C1 FMCGSUUBYTWNDP-GXSJLCMTSA-N 0.000 claims 1
- FMCGSUUBYTWNDP-ONGXEEELSA-N (1R,2S)-2-(dimethylamino)-1-phenyl-1-propanol Chemical compound CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 FMCGSUUBYTWNDP-ONGXEEELSA-N 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- XXJGBENTLXFVFI-UHFFFAOYSA-N 1-amino-methylene Chemical compound N[CH2] XXJGBENTLXFVFI-UHFFFAOYSA-N 0.000 claims 1
- GBBSAMQTQCPOBF-UHFFFAOYSA-N 2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane Chemical compound CB1OB(C)OB(C)O1 GBBSAMQTQCPOBF-UHFFFAOYSA-N 0.000 claims 1
- FUKFNSSCQOYPRM-UHFFFAOYSA-N 2-(dimethylamino)-1-phenylethanol Chemical compound CN(C)CC(O)C1=CC=CC=C1 FUKFNSSCQOYPRM-UHFFFAOYSA-N 0.000 claims 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 1
- 235000001258 Cinchona calisaya Nutrition 0.000 claims 1
- 229940126062 Compound A Drugs 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- FMCGSUUBYTWNDP-UHFFFAOYSA-N N-Methylephedrine Natural products CN(C)C(C)C(O)C1=CC=CC=C1 FMCGSUUBYTWNDP-UHFFFAOYSA-N 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 125000006241 alcohol protecting group Chemical group 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 238000004873 anchoring Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 125000005619 boric acid group Chemical class 0.000 claims 1
- QNRNUKUCUSOJKW-UHFFFAOYSA-N butyl-di(propan-2-yloxy)borane Chemical compound CCCCB(OC(C)C)OC(C)C QNRNUKUCUSOJKW-UHFFFAOYSA-N 0.000 claims 1
- 239000006227 byproduct Substances 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 239000003574 free electron Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000468 ketone group Chemical group 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- BHOFOFKBMGVFSG-UHFFFAOYSA-N methyl-di(propan-2-yloxy)borane Chemical compound CC(C)OB(C)OC(C)C BHOFOFKBMGVFSG-UHFFFAOYSA-N 0.000 claims 1
- KTMKRRPZPWUYKK-UHFFFAOYSA-N methylboronic acid Chemical compound CB(O)O KTMKRRPZPWUYKK-UHFFFAOYSA-N 0.000 claims 1
- 229940073569 n-methylephedrine Drugs 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 229960001404 quinidine Drugs 0.000 claims 1
- 229960000948 quinine Drugs 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 claims 1
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 125000005621 boronate group Chemical class 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000011915 stereoselective alkylation Methods 0.000 abstract 1
- 230000000707 stereoselective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/24—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
- C07C215/32—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton containing hydroxy groups and carbon atoms of two six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Postupak za asimetričnu alkilaciju karbonilne skupine u spoju (spoj K) koji sadrži karbonilnu skupinu i pričvrsnu skupinu odabrane iz skupine koja sadrži hidroksil, amino i sulfhidril skupine, naznačen time, da obuhvaća sljedeće korake: a) miješanje spoja K, kiralnog pomoćnog sredstva (spoj A), i derivata borne ili boronične kiseline; pri čemu derivat borne ili boronične kiseline je spoj formule (VI): gdje R1 je vodik, C1-10-alkil, C2-10-alkenil, C2-10-alkinil, C6-10-aril, C7-16 alkaril, 4-10 člani heterociklični talog, C1-10-alkoksi, C1-10-alkilamino, C1-10-alkiltio, hidroksi, ili cijano; i gdje R2 je halogen, hidroksi, C1-10-alkoksi, C6-10-ariloksi, C1-10-dialkilamino, ili 4-10 člani heterociklički talog povezan s S, N, ili O atomom na atom bora; i gdje R3 je halogen, amino, hidroksi, C1-10-alkoksi, C6-10-ariloksi, C1-10-dialkilamino, ili 4-10 člani heterociklički talog povezan s S, N, ili O atomom na atom bora; ili gdje R2 i R3 su povezani međusobno za tvorbu 5-10 člane cikličke strukture uključujući atom bora na koji su R2 i R3 povezani, dok ciklička struktura može sadržavati jedan ili više dodatnih atoma bora i/ili atoma kisika i/ili atoma dušika; i gdje je spoj K odabran iz skupine koja sadrži alfa-, beta-, gama- i delta-hidroksi-ketone ili -aldehide, alfa-, beta-, gama- i delta-amino-ketone ili -aldehide i alfa-, beta-, gama-i delta-sulfhidril-ketone ili -aldehide; pri čemu se spoj K prvo miješa sa derivatom borne ili boronične kiseline i tada se dodaje kiralno pomoćno sredstvo; ili se spoj K miješa prvo s kiralnim pomoćnim, sredstvom, a tada se dodaje derivat borne ili boronične kiseline; ili se kiralno pomoćno sredstvo i derivat borne ili boronične kiseline dodaju istovremeno u spoj K; te pri čemu se proizvede supstituirani derivat borne ili boronične kiseline, gdje atom bora povezuje kiralno pomoćno sredstvo na spoj K; idodavanje organometalnog spoja koji je spoj organomagnezija. Patent sadrži još 26 patentnih zahtjeva.
Claims (27)
1. Postupak za asimetričnu alkilaciju karbonilne skupine u spoju (spoj K) koji sadrži karbonilnu skupinu i pričvrsnu skupinu odabrane iz skupine koja sadrži hidroksil, amino i sulfhidril skupine, naznačen time,
da obuhvaća sljedeće korake:
a) miješanje spoja K, kiralnog pomoćnog sredstva (spoj A), i derivata borne ili boronične kiseline; pri čemu derivat borne ili boronične kiseline je spoj formule (VI):
[image]
gdje R1 je vodik, C1-10-alkil, C2-10-alkenil, C2-10-alkinil, C6-10-aril, C7-16 alkaril, 4-10 člani heterociklični talog, C1-10-alkoksi, C1-10-alkilamino, C1-10-alkiltio, hidroksi, ili cijano;
i gdje R2je halogen, hidroksi, C1-10-alkoksi, C6-10-ariloksi, C1-10-dialkilamino, ili
4-10 člani heterociklički talog povezan s S, N, ili O atomom na atom bora;
i gdje R3 je halogen, amino, hidroksi, C1-10-alkoksi, C6-10-ariloksi,
C1-10-dialkilamino, ili 4-10 člani heterociklički talog povezan s S, N, ili O atomom na atom bora; ili gdje R2 i R3 su povezani međusobno za tvorbu 5-10 člane cikličke strukture uključujući atom bora na koji su R2 i R3 povezani, dok ciklička struktura može sadržavati jedan ili više dodatnih atoma bora i/ili atoma kisika i/ili atoma dušika; i gdje je spoj K odabran iz skupine koja sadrži alfa-, beta-, gama- i delta-hidroksi-ketone ili -aldehide, alfa-, beta-, gama- i delta-amino-ketone ili -aldehide i alfa-, beta-, gama-i delta-sulfhidril-ketone ili -aldehide;
pri čemu se spoj K prvo miješa sa derivatom borne ili boronične kiseline i tada se dodaje kiralno pomoćno sredstvo; ili se spoj K miješa prvo s kiralnim pomoćnim, sredstvom, a tada se dodaje derivat borne ili boronične kiseline; ili se kiralno pomoćno sredstvo i derivat borne ili boronične kiseline dodaju istovremeno u spoj K; te pri čemu se proizvede supstituirani derivat borne ili boronične kiseline, gdje atom bora povezuje kiralno pomoćno sredstvo na spoj K; i
b) dodavanje organometalnog spoja koji je spoj organomagnezija.
2. Postupak prema zahtjevu 1, naznačen time, da se provodi u veličini oblika jedne posude.
3. Postupak prema zahtjevu 1 ili 2, naznačen time, da se reakcijska smjesa izlaže bitnom odstranjivanju sporednih proizvoda u koraku a) prije koraka b).
4. Postupak prema bilo kojem zahtjevu 1 do 3, naznačen time, da R1 je C1-10-alkil ili C1-10-alkoksi.
5. Postupak prema bilo kojem zahtjevu 1 do 4, naznačen time, da su R2i R3 identični i oni su hidroksi ili C1-10-alkoksi.
6. Postupak prema zahtjevu 5 u kombinaciji sa zahtjevom 3, naznačen time, da se reakcijska smjesa izlaže destilaciji prije koraka b) zbog odstranjivanja vode ili C1-10-alkanola.
7. Postupak prema bilo kojem zahtjevu 1 do 6, naznačen time, da je derivat borne ili boronične kiseline odabran od fenilboronične kiseline, trimetilborata, triizopropilborata, diizopropilbutilboronata, diizopropilmetilboronata, metilboronične kiseline ili trimetilboroksina.
8. Postupak prema zahtjevu 7, naznačen time, da uporišna skupina je hidroksil skupina.
9. Postupak prema bilo kojem zahtjevu 1 do 8, naznačen time, da je atom ugljika iz ugljične skupine odvojen od atoma ugljika koji nosi uporišnu skupinu sa 1 do 6 Angstroma.
10. Postupak prema zahtjevu 9, naznačen time, da je atom ugljika iz ugljične skupine odvojen od atoma ugljika koji nosi uporišnu skupinu sa 1,3 do 3 Angstroma.
11. Postupak prema bilo kojem zahtjevu 1 do 10, naznačen time, da je atom ugljika iz ugljične skupine odvojen od atoma ugljika koji nosi uporišnu skupinu sa 2 ili 3 atoma ugljika.
12. Postupak prema bilo kojem zahtjevu 1 do 11, naznačen time, da kiralno pomoćno sredstvo je kiralni alkohol.
13. Postupak prema zahtjevu 12, naznačen time, da kiralni alkohol obuhvaća strukturalni element formule (VII)
[image]
gdje C* je kiralni ugljik, n je cijeli broj od 0 do 3 te gdje X je heteroatom koji ima par slobodnih elektrona. ;
14. Postupak prema zahtjevu 13, naznačen time, da n je 1 i/ili X je dušik. ;
15. Postupak prema zahtjevu 14, naznačen time, da kiralni alkohol je kiralni amino alkohol. ;
16. Postupak prema zahtjevu 15, naznačen time, da je kiralni amino alkohol odabran od N-metilefedrina, N-metilpseudoefedrina, 2-dimetilamino-1-feniletanola, kinina, kinidina, cinkonidina ili cinkonina. ;
17. Postupak prema bilo kojem zahtjevu 1 do 16, naznačen time, da spoj organomagnezija je alkilmagnezij, alkenilmagnezij ili alkinilmagnezij. ;
18. Postupak prema bilo kojem zahtjevu 1 do 17, naznačen time, da je spoj K odabran iz skupine koja sadrži gama-hidroksi-ketone, gama-amino-ketone i gama-sulfhidril-ketone.;
19. Postupak prema zahtjevu 18, naznačen time, da u spoju K je fenilni supstituent smješten susjedno uz keto skupinu.;
20. Postupak prema bilo kojem zahtjevu 1 do 19, naznačen time, da spoju K je spoj formule (III)
[image]
gdje Y je cijano ili skupina koja se pretvara u cijano skupinu, dok skupina koja se pretvara u cijano skupinu je halogen, CF3-(CF2)n-SO2-O-, dok n je 0 do 8; CH2OH ili zaštićen CH2OH,CH2NH2ili zaštićen -CH2NH2, -CH2NO2, -CH2Cl, -CH2Br, -CH3, -NHR2, -CHNOH, -COOR3, -OR2, gdje R2 je vodik ili C1-6 alkilkarbonil; CONR3R4gdje R3 i R4 su odabrani od vodika, opcijski supstituiranih C1-6 alkila, aril-C1-6 alkila ili arila, ili R3 i R4 su spojeni zajedno za tvorbu 5-ili 6-članog prstena koji opcijski obuhvaća S, O, ili dodatno N atom; ili CHOR5OR6 gdje R5 i R6 su neovisno odabrani od alkila, arila, heteroarila, ili R5 i R6 su spojeni zajedno za tvorbu 5- ili 6-članog prstena; ili ostale zaštićene -CHO skupine, opcijski supstituirani oksazol, 4,5-dihidrooksazol, tiazol, ili 4,5-dihidrotiazol.;
21. Postupak prema zahtjevu 20, naznačen time, da organometalni spoj je organometalni spoj formule (VIII)
[image]
gdje crtkana linija je jednostruka, dvostruka ili trostruka veza; M je Mg; i Z je -CH2-N(CH3)2 ili skupina koja može biti pretvorena u -CH2-N(CH3)2, dok skupina koja može biti pretvorena u -CH2-N(CH3)2je odabrana od -CH2-LG, -CH2-NO2, -CN, C-N3, -CHO, -CH2-OPg, -CH2-NH2, -CH2-NHCH3, -CH2-NPg1Pg2, -CH2-NPg1CH3, -CO-N(CH3)2, -CH(Q1R11)(Q2R12), -C(Q1R13)(Q2R14)(Q3R15), -COOR16, -CH2-CO-NH2, -CH=CH-R17 ili -CONHR18, gdje Pg je zaštitna skupina za alkohol, Pg1 i Pg2 su zaštitne skupine za amino skupinu, R11 i R12 su neovisno odabrani od C1-6 alkila, C2-6 alkenila, C2-6 alkinila i opcijski C1-6 alkila supstituiranog arilom ili aril-C1-6 alkilom ili R11 i R12 zajedno tvore lanac od 2 do 4 ugljikova atoma, svaki od R13 do R17 su neovisno odabrani od C1-4 alkila, C2-6 alkenila, C2-6 alkinila i opcijski C1-6 alkila supstituiranog arilom ili aril-C1-6 alkilom, R18je vodik ili metil i Q1, Q2, i Q3 su odabrani od O i S; LG je halogen ili -O-SO2-R11 , a R11 je određen kao gore.;
22. Postupak prema zahtjevu 21, naznačen time, da M je Mg i gdje Z je -CH2-N(CH3)2 ili skupina koja se može pretvoriti u -CH2-N(CH3)2, pri čemu je dobiven diol formule (II) u obogaćenom enantiomernom ili čistom enantiomernom obliku,
[image]
dok Y je cijano skupina ili je skupina koja se pretvara u cijano skupinu kao što je određeno u zahtjevu 20.;
23. Postupak prema zahtjevu 22, naznačen time, da nadalje obuhvaća korak zatvaranja prstena diola formule (II) za tvorbu spoja formule (IX), gdje Y i Z su određeni gore u zahtjevu 22
[image] ;
24. Postupak prema zahtjevu 23, naznačen time, da spoj formule (IX) je escitalopram.;
25. Spoj formule (V)
[image]
naznačen time, da R1 je C1-10-alkil ili C1-10-alkoksi; dok Y je cijano skupina ili skupina koja se pretvara u cijano skupinu; i pri čemu O-R* je talog kiralnog alkohola, gdje skupina koja se pretvara u cijano skupinu je halogen, CF3-(CF2)n-SO2-O-gdje n je 0 do 8, CH2OH ili zaštićen CH2OH, CH2NH2 ili zaštićeni -CH2NH2, -CH2NO2, -CH2Cl, -CH2Br, -CH3, -NHR2, -CHNOH, -COOR3, -OR2, pri čemu R2 je vodik ili C1-6 alkilkarbonil; CONR3R4 gdje R3 i R4su odabrani od vodika, opcijski supstituiranih C1-6 alkila, aril-C1-6 alkila ili arila, ili R3 i R4 su spojeni zajedno za tvorbu 5- ili 6-članog prstena koji opcijski obuhvaća S, O, ili dodatno N atom; ili CHOR5OR6, dok R5 i R6 su neovisno odabrani od alkila, arila, heteroarila, ili R5 i R6 su spojeni zajedno za tvorbu 5- ili 6-članog prstena; ili ostale zaštićene -CHO skupine, opcijski supstituirani oksazol, 4,5-dihidrooksazol, tiazol, ili 4,5-dihidrotiazol.
26. Spoj prema zahtjevu 25, naznačen time, da R1 je -CH3, -OCH3 ili -OCH(CH3)2.
27. Spoj prema zahtjevu 25, naznačen time, da Y uključuje opcijski supstituirane oksazol, 4,5-dihidrooksazol, tiazol ili 4,5-dihidrotiazol skupine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0601286.8A GB0601286D0 (en) | 2006-01-23 | 2006-01-23 | Asymmetric synthesis |
PCT/EP2007/000516 WO2007082771A1 (en) | 2006-01-23 | 2007-01-22 | Carbonyl asymmetric alkylation |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20110492T1 true HRP20110492T1 (hr) | 2011-07-31 |
Family
ID=36010766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110492T HRP20110492T1 (hr) | 2006-01-23 | 2011-07-04 | Asimetrična alkilacija karbonila |
Country Status (19)
Country | Link |
---|---|
US (1) | US8288569B2 (hr) |
EP (1) | EP1966127B1 (hr) |
JP (1) | JP5081163B2 (hr) |
KR (1) | KR101379154B1 (hr) |
CN (1) | CN101460448B (hr) |
AT (1) | ATE504558T1 (hr) |
AU (1) | AU2007207103B2 (hr) |
BR (1) | BRPI0706735B1 (hr) |
CA (1) | CA2636256C (hr) |
DE (1) | DE602007013690D1 (hr) |
EA (1) | EA016650B1 (hr) |
ES (1) | ES2364502T3 (hr) |
GB (1) | GB0601286D0 (hr) |
HR (1) | HRP20110492T1 (hr) |
IL (1) | IL192628A (hr) |
PL (1) | PL1966127T3 (hr) |
SI (1) | SI1966127T1 (hr) |
TW (1) | TWI387577B (hr) |
WO (1) | WO2007082771A1 (hr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110130591A1 (en) * | 2009-06-03 | 2011-06-02 | Boehringer Ingelheim International Gmbh | Steroselective synthesis of certain trifluoromethyl-substituted alcohols |
EP3680240A1 (en) * | 2012-03-14 | 2020-07-15 | Merck Sharp & Dohme Corp. | Asymmetric phase transfer catalysis |
PT3013801T (pt) * | 2013-06-26 | 2018-11-16 | Syngenta Participations Ag | Processo para a preparação estereosseletiva de uma pirazol-carboxamida |
CN107074750B (zh) * | 2014-11-14 | 2022-03-25 | 浙江华海药业股份有限公司 | 一种拆分西酞普兰中间体5-氰二醇的方法 |
KR20160109083A (ko) | 2015-03-09 | 2016-09-21 | 엔팩토리주식회사 | 휴대용 앱세서리를 이용한 공기품질 정보제공 시스템 및 방법 |
US10111356B2 (en) | 2016-03-31 | 2018-10-23 | Oracle International Corporation | System for electrical connection of printed circuit boards and backplanes in server enclosure |
CN106892837A (zh) * | 2017-03-23 | 2017-06-27 | 浙江师范大学 | 4‑[4‑(二甲氨基)‑1‑(4‑氟苯基)‑1‑羟丁基]‑3‑羟甲基苯腈的合成 |
CN108947869A (zh) * | 2017-05-25 | 2018-12-07 | 万全万特制药江苏有限公司 | 一种艾司西酞普兰工艺杂质的制备方法 |
CN108640855A (zh) * | 2018-06-11 | 2018-10-12 | 中南林业科技大学 | 一种依地普仑中间体的合成方法及其中间体 |
CN108640856B (zh) * | 2018-06-11 | 2021-06-25 | 淮阴工学院 | 一种依地普仑中间体的不对称合成方法及其中间体 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1526331A (en) | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
GB8419963D0 (en) * | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
GB8814057D0 (en) | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
UA62985C2 (en) | 1997-11-10 | 2004-01-15 | Lunnbeck As H | A method for the preparation of citalopram |
ES2229774T3 (es) * | 1999-10-25 | 2005-04-16 | H. Lundbeck A/S | Metodo para la preparacion de citalopram. |
FR2805812A1 (fr) | 2000-02-24 | 2001-09-07 | Lundbeck & Co As H | Procede de preparation du citalopram |
IES20010157A2 (en) | 2000-03-03 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
JP2003527387A (ja) | 2000-03-13 | 2003-09-16 | ハー・ルンドベック・アクチエゼルスカベット | シタロプラムの製造方法 |
AR034759A1 (es) | 2001-07-13 | 2004-03-17 | Lundbeck & Co As H | Metodo para la preparacion de escitalopram |
PT1414435E (pt) | 2001-07-31 | 2005-05-31 | Lundbeck & Co As H | Composicao cristalina contendo escitalopram |
DE60108105T2 (de) * | 2001-08-02 | 2005-12-08 | Infosint Sa | Verfahren zur Herstellung von 5-substituierten Isobenzofuranen |
PE20040991A1 (es) | 2002-08-12 | 2004-12-27 | Lundbeck & Co As H | Separacion de intermediarios para la preparacion de escitalopram |
WO2005066185A1 (en) | 2004-01-12 | 2005-07-21 | Jubilant Organosys Limited | Process for preparing 5-substituted -1-(4-fluorophenyl) -1,3-dihydroisobenzofurans |
JP2005247710A (ja) * | 2004-03-01 | 2005-09-15 | Sumitomo Chemical Co Ltd | 光学活性シタロプラムの製造方法、その中間体およびその製造方法 |
-
2006
- 2006-01-23 GB GBGB0601286.8A patent/GB0601286D0/en not_active Ceased
-
2007
- 2007-01-22 EA EA200801673A patent/EA016650B1/ru not_active IP Right Cessation
- 2007-01-22 KR KR1020087017910A patent/KR101379154B1/ko active IP Right Grant
- 2007-01-22 DE DE602007013690T patent/DE602007013690D1/de active Active
- 2007-01-22 AU AU2007207103A patent/AU2007207103B2/en not_active Ceased
- 2007-01-22 CN CN2007800029031A patent/CN101460448B/zh not_active Expired - Fee Related
- 2007-01-22 TW TW096102355A patent/TWI387577B/zh not_active IP Right Cessation
- 2007-01-22 ES ES07702933T patent/ES2364502T3/es active Active
- 2007-01-22 CA CA2636256A patent/CA2636256C/en not_active Expired - Fee Related
- 2007-01-22 EP EP07702933A patent/EP1966127B1/en active Active
- 2007-01-22 US US12/223,096 patent/US8288569B2/en active Active
- 2007-01-22 SI SI200730634T patent/SI1966127T1/sl unknown
- 2007-01-22 PL PL07702933T patent/PL1966127T3/pl unknown
- 2007-01-22 BR BRPI0706735A patent/BRPI0706735B1/pt not_active IP Right Cessation
- 2007-01-22 AT AT07702933T patent/ATE504558T1/de active
- 2007-01-22 JP JP2008550696A patent/JP5081163B2/ja not_active Expired - Fee Related
- 2007-01-22 WO PCT/EP2007/000516 patent/WO2007082771A1/en active Application Filing
-
2008
- 2008-07-03 IL IL192628A patent/IL192628A/en not_active IP Right Cessation
-
2011
- 2011-07-04 HR HR20110492T patent/HRP20110492T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2636256C (en) | 2014-04-29 |
TW200800858A (en) | 2008-01-01 |
IL192628A (en) | 2013-04-30 |
IL192628A0 (en) | 2009-02-11 |
US20110009648A1 (en) | 2011-01-13 |
TWI387577B (zh) | 2013-03-01 |
SI1966127T1 (sl) | 2011-08-31 |
KR20080090444A (ko) | 2008-10-08 |
CN101460448A (zh) | 2009-06-17 |
ES2364502T3 (es) | 2011-09-05 |
US8288569B2 (en) | 2012-10-16 |
PL1966127T3 (pl) | 2011-10-31 |
EA016650B1 (ru) | 2012-06-29 |
DE602007013690D1 (de) | 2011-05-19 |
EP1966127B1 (en) | 2011-04-06 |
JP5081163B2 (ja) | 2012-11-21 |
AU2007207103B2 (en) | 2011-01-06 |
ATE504558T1 (de) | 2011-04-15 |
CN101460448B (zh) | 2013-05-15 |
KR101379154B1 (ko) | 2014-04-11 |
BRPI0706735B1 (pt) | 2016-11-22 |
BRPI0706735A2 (pt) | 2011-04-05 |
EA200801673A1 (ru) | 2009-02-27 |
EP1966127A1 (en) | 2008-09-10 |
CA2636256A1 (en) | 2007-07-26 |
GB0601286D0 (en) | 2006-03-01 |
JP2009523749A (ja) | 2009-06-25 |
WO2007082771A1 (en) | 2007-07-26 |
AU2007207103A1 (en) | 2007-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20110492T1 (hr) | Asimetrična alkilacija karbonila | |
Frye et al. | Pentacoordinate silicon compounds. V. Novel silatrane chemistry | |
RS51983B (en) | SYNTHESIS OF ORGANOBORIC ACID AND ORGANOBORIC ACID COMPOUNDS | |
JP2015528840A5 (hr) | ||
AR029658A1 (es) | Metodo para la preparacion de citalopram, una composicion farmaceutica antidepresiva, e intermediarios | |
HK1169984A1 (en) | Diphenyl-pyrazolopyridine compounds, their preparation and their application as modulators of the nuclear receptor not | |
CA2674262C (fr) | Inhibiteur de corrosion | |
JP2017515949A5 (hr) | ||
MA30767B1 (fr) | Composes azabicycliques en tant qu'inhibiteurs de reabsorption de monoamines | |
GB1117082A (en) | Process for the preparation of substituted n-cyclopropylethylene diamines | |
US3340286A (en) | p-diethylaminophenyl silanes | |
Ghereg et al. | 1, 3‐Dipole Behavior of Phosphagermaallene Tip (tBu) Ge C PMes* Leading to a Phosphagermaheterocyclic Carbene | |
RU2010115563A (ru) | Ускоренное восстановление органических веществ боранами | |
HRP970497A2 (en) | Processes and intermediates for preparing sibstituted chromanol derivatives | |
CN101657457A (zh) | 用于制备1,3,2-氧杂硼啶化合物的方法 | |
JP2938722B2 (ja) | アクリル官能性シラン化合物の重合禁止剤 | |
JP2013507343A5 (hr) | ||
RU2012113138A (ru) | Автоматизированный радиохимический синтез | |
IN2012DN02871A (hr) | ||
US2711417A (en) | Preparation of organosilylphenols | |
FR3027305A1 (fr) | Synthese d'esters par fonctionnalisation du co2 | |
WO2012074988A1 (en) | Rotigotine ionic liquid | |
JP2018184350A5 (hr) | ||
US7402623B1 (en) | Composition and process for treating concrete | |
Alanqari | Synthesis of Functionalized Potassium Alkyl and Alkenyltrifluoroborate Salts via the Hydroboration of Functionalized Terminal Alkenes and Alkynes with Dicyclohexylborane and Two Groups Reductive-Alkylation |